YJ Capital and existing investor GV were among the partcipants in the latest round for metabolic disease treatment developer Fractyl.
US-based diabetes therapy developer Fractyl Laboratories has received $55m in a series E round featuring YJ Capital and GV, respective subsidiaries of internet company Yahoo Japan and internet technology conglomerate Alphabet.
Venture capital firm Taiwania Capital Management led the round, which included Bessemer Venture Partners (BVP), General Catalyst, Domain Associates, Mithril Capital Management, Emergent Medical Partners, True Ventures, Catalio Capital Management and CDIB Venture Capital, part of financial services provider China Development Financial.
Founded in 2010, Fractyl is working on…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
